Concepedia
Statistics
Publications
4
Citations
460
H-Index
Active since
2006
Affiliations
University of Kentucky(Current)
Houston Methodist
University of North Carolina at Chapel Hill
Clinical Research Institute
Alaska Heart and Vascular Institute
Shelley K. Myles is an author at University of Kentucky specializing in pharmacology, anticoagulant therapy, and antithrombotic therapy.
Publications per year
2006–2010
First-in-Human Experience of an Antidote-Controlled Anticoagulant Using RNA Aptamer Technology
Christopher K. Dyke, Steven R. Steinhubl, Neal S. Kleiman et al. · Circulation · 2006 · 221 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +17
Phase 1b Randomized Study of Antidote-Controlled Modulation of Factor IXa Activity in Patients With Stable Coronary Artery Disease
Mark Y. Chan, Mauricio G. Cohen, Christopher K. Dyke et al. · Circulation · 2008 · 130 citations · Full text
First Clinical Application of an Actively Reversible Direct Factor IXa Inhibitor as an Anticoagulation Strategy in Patients Undergoing Percutaneous Coronary Intervention
Mauricio G. Cohen, Drew A. Purdy, Joseph S. Rossi et al. · Circulation · 2010 · 98 citations
Medicine, Cardiology, Pharmacology +17
The effect of aspirin on endothelial progenitor cell biology: Preliminary investigation of novel properties
Junyang Lou, Thomas J. Povsic, Jason D. Allen et al. · Thrombosis Research · 2010 · 11 citations
Veterinary Medicine, Cell Biology, Pharmacology +16
1–4 of 4